Tentech (CEO Ro Young Woo) announced on the 21st that
it had successfully completed an investment of 1 billion won
from NH Investment & Securities.
An official from Tentech said, "We launched Korea's First 2Line HIFU,
and domestic sales have been steadily increasing. Recently we sold 20 devices
per month and as user's satisfaction is high we going to hit up to 50 devices per month
in domestic sales after a year. "Overseas exports are also steadily increasing,
and licensing is in progress in Taiwan, Singapore, Mexico, and Brazil," he said.
So far, more than 20 countries have signed exclusive distributorship agreements
in overseas, including Japan, Taiwan, Hong Kong, Singapore, Mexico, Iran, Saudi Arabia,
Russia, Thailand, Romania, Moldova, Lithuania, Latvia, Estonia, Finland, and Sweden.
An official from Tentech said, "For 10Therma, scheduled to be released domestically in April this year,
compared to Thermage FLX conducted at the University of Dermatology in Gachon,
the level of collagen production in the first month increased by 11% points for Thermage FLX
from 46% to 57%, whereas 10Therma increased by 45%. to 60%, an increase of 15% points.”
10Therma evaded all patents of Thermage FLX, and currently has eight international patents pending.
If the FDA will be approved in October of this year and European CE at the end of the year,
it is expected that significant sales will occur not only in domestic market but also abroad.
Tentech's CEO Ro Young Woo said, "Tentech, based on its own technology, aims to grow into a
world-leading dermatological laser manufacturer beyond Korea, and will grow into a specialized
dermatology company that manufactures botox, fillers, and boosting products."
Tentech with this investment attraction as an opportunity is preparing to go public on KOSDAQ next spring.